Imunon (IMNN) Q3 2026 Earnings Call Transcript
Enrollment is ahead of plan in its pivotal ovarian cancer trial as cash tightens.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.